Glutamine in the central nervous system: Function and dysfunction

Frontiers in Bioscience

Volumn 12, Issue 1, 2007, Pages 332-343

  Albrecht, Jan ^a   Sonnewald, Ursula ^b   Waagepetersen, Helle S ^c   Schousboe, Arne ^c  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Glutamine; Glutamine carriers; Glutamine synthetase; Hyperammonemia; Magnetic resonance spectroscopy; MSO; Phosphate activated glutaminase; Review

Indexed keywords

EID: 34249786877     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2067     Document Type: Article

References (123)

1. Nitsch C., B. Schmude & P. Haug: Alterations in the content of amino acid neurotransmitters before the onset and during the course of methoxypyridoxine-induced seizures in individual rabbit brain regions. J Neurochem 40, 1571-1580 (1983)
2. Tossman J., A. Delin, L. S. Eriksson & U. Ungerstedt: Brain cortical amino acids measured by intracerebral dialysis in portacaval shunted rats. Neurochem Res 12, 265-269 (1987)
3. Eloqayli H, C. Bredo Dahl, K. G. Götestam, G. Unsgård & U. Sonnewald: Changes of glial-neuronal interaction and metabolism after a subconvulsive dose of pentylenetetrazole. Neurochem Int 45, 739-745 (2004)
4. Hamberger A. & B. Nyström: Extra- and intracellular amino acids in the hippocampus during development of hepatic encephalopathy. Neurochem Res 9, 1181-1192 (1984)
5. Kanamori K. & B. D. Ross: Quantitative determination of extracellular glutamine concentration in rat brain, and its elevation in vivo by system A transport inhibitor, alpha-(methylamino)isobutyrate. J Neurochem 90, 203-210 (2004)
6. Xu C. Y., D. J. McAdoo, M. G. Hughes, G. Robak & R. de Castro Jr: Considerations in the determination by microdialysis of resting extracellular amino acid concentrations and release upon spinal cord injury. Neuroscience 86, 1011-1021 (1998)
7. Reichel A, D. J. Begley & A. Ermisch: Changes in amino acid levels in rat plasma, cisternal cerebrospinal fluid, and brain tissue induced by intravenously infused arginine-vasopressin. Peptides 16, 965-71 (1995)
8. Gårseth M., U. Sonnewald, L. R. White, M. Rød, J. A. Zwart, Ø. Nygaard & J. Aasly: Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: indication of glial energy impairment in Huntington Chorea, but not Parkinson Disease J Neurosci Res 60, 779-782 (2000)
9. Dejong C. H. C., N. E. P. Deutz & P. B. Soeters: Cerebral cortex ammonia and glutamine metabolism in two rat models of chronic liver insufficiency-induced hyperarnmonemia: Influence of pair-feeding. J Neurochem 60, 1047-1057 (1993)
10. Smith Q. R., S. Momma, M. Aoyagi & S. I. Rapoport: Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem 49, 1651-1658 (1987)
11. Norenberg M. D. & A. Martínez-Hernández: Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 161, 303-310 (1979)
12. Riepe R. E. & M. D. Norenberg: Glutamine synthetase in the developing rat retina: an immunohistochemical study. Exp Eye Res 27, 435-444 (1978)
13. Cammer W.: Glutamine synthetase in the central nervous system is not confined to astrocytes. J Neuroimmunol 26, 173-178 (1990)
14. Hayashi M., R. Hayashi, H. Tanii, K. Hashimoto & A. J. Patel: The influence of neuronal cells on the development of glutamine synthetase in astrocytes in vitro. Brain Res 469, 37-42 (1988)
15. Mearow K. M., J. F. Mill & E. Freese: Neuron-glial interactions involved in the regulation of glutamine synthetase. Glia 3, 385-392 (1990)
16. Westergaard N., O. M. Larsson, B. Jensen & A. Schousboe: Synthesis and release of GABA in cerebral cortical neurons co-cultured with astrocytes from cerebral cortex or cerebellum. Neurochem Int 20, 567-575 (1992)
17. Derouiche A. & M. Frotscher: Astroglial processes around identified glutamatergic synapses contain glutamine synthetase: evidence for transmitter degradation. Brain Res 552, 346-350 (1991)
18. Derouiche A. & T. G. Ohm: Glutamine synthetase immunoreactivity in the human hippocampus is lamina- specific. Neurosci Lett 165, 179-182 (1994)
19. Fonseca L. L., M. A. Monteiro, P. M. Alves, M. J. Carrondo & H. Santos: Cultures of rat astrocytes challenged with a steady supply of glutamate: new model to study flux distribution in the glutamate-glutamine cycle. Glia 51, 286-296 (2005)
20. Laake J. H., T. A. Slyngstad, F. M. Haug, & O. P. Ottersen: Glutamine from glial cells is essential for the maintenance of the nerve terminal pool of glutamate: immunogold evidence from hippocampal slice cultures. J Neurochem 65, 871-881 (1995)
21. Aoki C., T. Kaneko, A. Starr, & V. M. Pickel: Identification of mitochondrial and non-mitochondrial glutaminase within select neurons and glia of rat forebrain by electron microscopic immunocytochemistry. J Neurosci Res 28, 531-548 (1991)
22. Roberg B., I. A. Torgner & E. Kvamme: The orientation of phosphate activated glutaminase in the inner mitochondrial membrane of synaptic and non-synaptic rat brain mitochondria. Neurochem Int 27, 367-376 (1995)
23. Laake J. H., Y. Takumi, J. Eidet, I. A. Torgner, B. Roberg, E. Kvamme & O. P. Ottersen: Postembedding immunogold labelling reveals subcellular localization and pathway-specific enrichment of phosphate activated glutaminase in rat cerebellum. Neuroscience 88, 1137-1151 (1999)
24. Nimmo G. A. & K. F. Tipton: The distribution of soluble and membrane-bound forms of glutaminase in pig brain. J Neurochem 33, 1083-1084 (1979)
25. Kvamme E., G. Svenneby, L. Hertz & A. Schousboe: Properties of phosphate activated glutaminase in astrocytes cultured from mouse brain. Neurochem Res 7, 761-770 (1982)
26. Schousboe A., L. Hertz, G. Svenneby & E. Kvamme: Phosphate activated glutaminase activity and glutamine uptake in primary cultures of astrocytes. J Neurochem 32, 943-950 (1979)
27. Kovacevic Z. & J. D. McGivan: Mitochondrial metabolism of glutamine and glutamate and its physiological significance. Physiol Rev 63, 547-605 (1983)
28. Curthoys N. & M. Watford: Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 15, 133-159 (1995)
29. Elgadi K. M., R. A. Meguid, M. Qian, W. W. Souba & S. F. Abcouwer: Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genomics 1, 51-62 (1999)
30. Aledo J. C., P. M. Gómez-Fabre, L. Olalla & J. Marquez: Identification of two human glutaminase loci and tissue-specific expression of the two related genes. Mamm Genome 11, 1107-1110 (2000)
31. Olalla L., A. Gutiérrez, J. A. Campos, Z. U. Khan, F. Alonso, J. A. Segura, J. Marquez & J. C. Aledo: Nuclear localization of L-glutaminase in mammalian brain. J Biol Chem 277, 38939-38944 (2002)
32. Dawson Jr. R. & D. R. Wallace: Regulation of phosphate-activated glutaminase (PAG) by glutamate analogues. Neurochem Res 18, 125-32 (1993)
33. Albrecht J., M. Dolińska, W. Hilgier, A. W. Lipkowski & J. Nowacki: Modulation of glutamine uptake and phosphate-activated glutaminase activity in rat brain mitochondria by amino acids and their synthetic analogues. Neurochem Int 36, 341-347 (2000)
34. Roberg B., I. A. Torgner & E. Kvamme: Inhibition of glutamine transport in rat brain mitochondria by some amino acids and tricarboxylic acid cycle intermediates. Neurochem Res 24, 811-816 (1999)
35. Bröer A., N. Brookes, V. Ganapathy, K. S. Dimmer, C. A. Wagner, F. Lang & S. Bröer: The astroglial ASCT2 amino acid transporter as a mediator of glutamine efflux. J Neurochem 73, 2184-2194 (1999)
36. Bröer A., A. Albers, I. Sewatian, R. E. Edwards, F. A. Chaudhry, F. Lang, C. Wagner & S. Bröer: Regulation of the glutamine transporter SN1 by extracellular pH and intracellular sodium ions. J Physiol 539, 3-14 (2002)
37. Bröer S. & N. Brookes: Transfer of glutamine between astrocytes and neurons. J Neurochem 77, 705-719 (2001)
38. Varoqui H., H. Zhu, D. Yao, H. Ming & J. D. Erickson: Cloning and functional identification of a neuronal glutamine transporter. J Biol Chem 275, 4049-4054 (2000)
39. Mackenzie B., M. K. Schafer, J. D. Erickson, M. A. Hediger, E. Weihe & H. Varoqui: Functional properties and cellular distribution of the system A glutamine transporter SNAT1 support specialized roles in central neurons. J Biol Chem 278, 23720-23730 (2003)
40. MacKenzie B. & J. D. Erickson: Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family. Pflugers Arch Eur J Physiol 447, 784-795 (2004)
41. Dolińska M., B. Zablocka, U. Sonnewald & J. Albrecht: Glutamine uptake and expression of mRNA's of glutamine transporting proteins in mouse cerebellar and cerebral cortical astrocytes and neurons. Neurochem Int 44, 75-81 (2004)
42. Bacci A., G. Sancini, C. Verderio, S. Armano, E. Pravettoni, R. Fesce, S. Franceschetti & M. Matteoli: Block of glutamate-glutamine cycle between astrocytes and neurons inhibits epileptiform activity in hippocampus. J Neurophysiol 88, 2302-2310 (2002)
43. Hulsmann S., Y. Oku, W. Zhang & D. W. Richter: Metabolic coupling between glia and neurons is necessary for maintaining respiratory activity in transverse medullary slices of neonatal mouse. Eur J Neurosci 12, 856-862 (2000)
44. Rae C., N. Hare,W. A. Bubb, S. R. McEwan, A. Bröer, J. A. McQuillan, V. J. Balcar, A. D. Conigrave & S. Bröer: Inhibition of glutamine transport depletes glutamate and GABA neurotransmitter pools: further evidence for metabolic compartmentation. J Neurochem 85, 503-514 (2003)
45. Chaudhry F. A., R. J. Reimer, D. Krizaj, D. Barber, J. Storm-Mathisen, D. R. Copenhagen & R. H. Edwards: Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission. Cell 99, 769-780 (1999)
46. Boulland J., K. K. Osen, L. M. Levy, N. C. Danbolt, R. H. Edwards, J. Storm-Mathisen & F. A. Chaudhry: Cell-specific expression of the glutamine transporter SN1 suggests differences in dependence on the glutamine cycle. Eur J Neurosci 15, 1615-1631 (2002)
47. Cubelos B., I. M. Gonzalez-Gonzalez, C. Gimenez & F. Zafra: Amino acid transporter SNAT5 localizes to glial cells in the rat brain. Glia 49, 230-244 (2005)
48. Deitmer J. W., A. Bröer & S. Bröer: Glutamine efflux from astrocytes in mediated by multiple pathways. J Neurochem 87, 127-135 (2003)
49. Bröer A., J. W. Deitmer & S. Bröer: Astroglial glutamine transport by system N is upregulated by glutamate. Glia 48, 298-310 (2004)
50. Kanamori K., B. D. Ross & R. W. Kondrat: Glial uptake of neurotransmitter glutamate from the extracellular fluid studied in vivo by microdialysis and (13)C NMR. Glial uptake of neurotransmitter glutamate from the extracellular fluid studied in vivo by microdialysis and (13)C NMR. J Neurochem 83, 682-695 (2002)
51. Xiang J., S. R. Ennis, G. E. Abdelkarim, M. Fujisawa, N. Kawai & R. F. Keep: Glutamine transport at the blood-brain and blood-cerebrospinal fluid barriers. Neurochem Int 43, 279-288 (2003)
52. +-dependent neutral amino acid transporters A, ASC, and N of the blood-brain barrier: mechanisms for neutral amino acid removal. Am J Physiol Endocrinol Metab 287, E622-E629 (2004)
53. Minn A.: Glutamine uptake by isolated rat brain mitochondria. Neuroscience 7, 2859-2865 (1982)
54. Steib A., A. Rendon, J. Mark & J. Borg: Preferential glutamine uptake in rat brain synaptic mitochondria. FEBS Letters 207, 63-68 (1986)
55. Dolińska M., W. Hilgier & J. Albrecht: Ammonia stimulates glutamine uptake to nonsynaptic cerebral mitochondria of the rat. Neurosci Lett 11, 175-184 (1996)
56. Roberg B., I. A. Torgner & E. Kvamme: Glutamine transport in rat brain synaptic and non-synaptic mitochondria. Neurochem Res 24, 383-390 (1999)
57. Ziemińska E., W. Hilgier, H. S. Waagepetersen, L. Hertz, U. Sonnewald, A. Schousboe & J. Albrecht: Analysis of glutamine accumulation in rat brain mitochondria in the presence of a glutamine uptake inhibitor, histidine, reveals glutamine pools with a distinct access to deamidation. Neurochem Res 29, 2121-2123 (2004)
58. 13C]NMR spectroscopy that glutamine from astrocytes is a precursor for GABA synthesis in neurons. Neurochem Int 22, 19-29 (1993)
59. + and glutamate activates different neurotransmitter release mechanisms in GABAergic neurons: vesicular versus non-vesicular release of GABA. Neuroscience 54, 1019-1034 (1993)
60. 13C magnetic resonance spectroscopy. J Neurosci Res 63, 347-355 (2001)
61. Waagepetersen H. S., H. Qu., U. Sonnewald., K Shimamoto & A. Schousboe: Role of glutamine and neuronal glutamate uptake in glutamate homeostasis and synthesis during vesicular release in cultured glutamatergic neurons. Neurochem Int 47, 92-102 (2005)
62. Yu A. C., J. Drejer, L. Hertz & A. Schousboe: Pyruvate carboxylase activity in primary cultures of astrocytes and neurons. J Neurochem 41, 1484-1487 (1983)
63. Shank R. P., G. S. Bennett, S. O. Freytag. & G. L. Campbell: Pyruvate carboxylase: an astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools. Brain Res 329, 364-367 (1985)
64. Faff-Michalak L. & J. Albrecht: Aspartate aminotransferase, malate dehydrogenase, and pyruvate-carboxylase activities in rat cerebral synaptic and nonsynaptic mitochondria: Effects of in vitro treatment with ammonia, hyperammonemia and hepatic encephalopathy. Metabol Brain Dis 6, 187-197 (1991)
65. Waagepetersen H. S., U. Sonnewald, O. M. Larsson & A. Schousboe: Multiple compartments with different metabolic characteristics are involved in biosynthesis of intracellular and released glutamine and citrate in astrocytes. Glia 35, 246-252 (2001).
66. Danbolt N. C.: Glutamate uptake. Prog Neurobiol 65, 1-105 (2001)
67. Schousboe A., A. Sarup, L. K. Bak., H. S. Waagepetersen & O. M. Larsson: Role of astrocytic transport processes in glutamatergic and GABAergic neurotransmission. Neurochem Int 45, 521-527 (2004)
68. Sonnewald U., N. Westergaard & A. Schousboe: Glutamate transport and metabolism in astrocytes. Glia 21, 56-63 (1997)
69. McKenna M. C., U. Sonnewald, X. Huang, J. Stevenson & H. R. Zielke: Exogenous glutamate concentration regulates the metabolic fate of glutamate in astrocytes. J Neurochem 66, 386-393 (1996)
70. 13C NMR spectroscopy: incorporation of more label into lactate than into glutamine demonstrates the importance of the tricarboxylic acid cycle. J Neurochem 61, 1179-82 (1993)
71. 13C] glutamine in cultured astrocytes studied by NMR spectroscopy: first evidence of astrocytic pyruvate recycling. J Neurochem 67, 2566-2572 (1996)
72. Cooper A. J. L. & F. Plum: Biochemistry and physiology of brain ammonia. Physiol Rev 67, 440-519 (1987)
73. Albrecht J. & E. A. Jones: Hepatic encephalopathy: Molecular mechanisms underlying the clinical syndrome. J Neural Sci 170, 138-146 (1999)
74. Conn H. O. & J. Birchen Hepatic encephalopathy: Syndromes and therapies. Bloomington: Medi-Ed Press (1994)
75. Norenberg M. D.: Astrocytic-ammonia interactions in hepatic encephalopathy. Semin Liver Dis 16, 245-253 (1996)
76. Traber P., M. G. DalCanto, D. Ganger & A. T. Blei: Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure. Hepatology 7, 1257-1261 (1987)
77. Ede J. R. & R. R. Williams: Hepatic encephalopathy and cerebral edema. Semin Liv Disease 6, 107-118 (1986)
78. O'Grady J. G., G. J. Alexander, K. M. Hayllar & R. Williams: Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97, 439-445 (1989)
79. Blei A. T., S. Olaffson, G. Themen & R. F. Butterworth: Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology 19, 1437-1444 (2000)
80. Groeneweg M., W. Moerland, J. C. Quero, W. C. J. Hop, P. F. Krabbe & S. W. Schalm: Screening of subclinical hepatic encephalopathy. J Hepatol 32, 748-753 (2000)
81. Mattarozzi K., A. Stracciari, L. Vignatelli, R. D'Alessandro, M. C. Morelli & M. Guarino: Minimal hepatic encephalopathy. Arch Neural 61(2), 242-247 (2004)
82. Häussinger D., G. Kircheis, F. Schliess, R. Schliess & S. Vom Dahl: Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 32, 1035-1038 (2000)
83. Record C. O., B. Buxton, R. A. Chase, G. Curzon, I. M. Murray-Lyon & R. Williams: Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 6, 387-394 (1976)
84. Lavoie J., J. F. Giguere, G. P. Layrargues & R. F. Butterworth: Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J Neurochem 49, 692-697 (1987)
85. Laubenberger J., D. Häussinger, S. Bayer, H. Gufler, J. Hennig & M. Langer: Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 112, 1610-1616 (1997)
86. Zanchin G., P. Rigotti, N. Dussini, P. Vassanelli & L. Battistin: Cerebral amino acid levels and uptake in rats after portocaval anastomosis: II. Regional studies in vivo. J Neurosci Res 4, 301-310 (1979)
87. Giguere J. F. & R. F. Butterworth: Amino acid changes in regions of the CNS in relation to function in experimental portal-systemic encephalopathy. Neurochem Res 9, 1309-1321 (1984)
88. Hilgier W. & J. E. Olson: Brain ion and amino acid contents during edema development in hepatic encephalopathy. J Neurochem 62, 197-204 (1994)
89. Hawkins R. A., J. Jessy, A. M. Mans & M. R. De Joseph: Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy. J Neurochem 60, 1000-1006 (1993)
90. Mans A. M., M. R. DeJoseph & R. A. Hawkins: Metabolic abnormalities and grade of encephalopathy in acute hepatic failure. J Neurochem 63, 1829-1838 (1994)
91. Waniewski R. A. & D. L. Martin: Exogenous glutamate is metabolized to glutamine and exported by rat promary astrocyte cultures. J Neurochem 47, 304-313 (1986)
92. Warren K. S. & S. Schenker: Effect of an inhibitor of glutamine synthesis (methionine sulfoximine) on ammonia toxicity and metabolism. J Lab Clin Med 64, 442-449 (1964)
93. Swain M., R. F. Butterworth & A. Blei: Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure. Hepatology 15, 449-453 (1992)
94. Takahashi H., R. C. Koehler, S. W. Brusilow & R. J. Traystman: Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol 261, H825-H829 (1991)
95. Norenberg M. D. & A. S. Bender: Astrocyte swelling in liver failure: role of glutamine and benzodiazepines. Acta Neurochir 60, 24-27 (1994)
96. Zwingmann C., U. Flogerl, J. Pfeuffer & D. Leibfritz: Effects of ammonia exposition on glioma cells: Changes in cell volume and organic osmolytes studied by diffusion-weighted and high-resolution NMR spectroscopy. Dev Neurosci 22, 463-471 (2000)
97. Willard-Mack C. L., R. C. Koehler, T. Hirata, L. C. Cork, H. Takahashi, R. J. Traystman & S. W. Brusilow: Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in the rat. Neuroscience 71, 589-599 (1996)
98. Tanigami H., A. Rebel, L. J. Martin, T. Y. Chen, S. W. Brusilow, R. J. Traystman & R. C. Koehler: Effect of glutamine synthetase inhibition on astrocyte swelling and altered astroglial protein expression during hyperammonemia in rats. Neuroscience 131, 437-49 (2005)
99. Master S., J. Gottstein & A. Blei: Cerebral blood flow and the development ofammonia-induced brain edema in rats after portacaval anastomosis. Hepatology 30, 876-80 (1999)
100. 2 responsivity by glutamine synthesis inhibition in hyperammonemic rats. Circ Res 71, 1220-1230 (1992)
101. Sugimoto H., R. C. Koehler, D. A. Wilson, S. W. Brusilow & R. J. Traystman: Methionine sulfoximine, a glutamine synthetase inhibitor, attenuates increased extracellular potassium activity during acute hyperammonemia. J Cereb Blood Flow and Metab 17, 44-49 (1997)
102. Hawkins R. A. & J. Jessy: Hyperammonaemia does impair brain function in the absence of net glutamine synthesis. Biochem J 211, 697-703 (1991)
103. Shawcross D. L., S. Balata, S. W. Olde Damink, P. C. Hayes, J. Wardlaw, I. Marshall, N. E. Deutz, R. Williams & R. Jalan: Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Am J Physiol Gastrointest Liver Physiol 287, G503-G509 (2004)
104. Brusilow S. W.: Hepatic encephalopathy (letter) N Engl J Med 314, 786 (1986)
105. Cordoba J., J. Gottstein & A. T. Blei: Glutamine, myoinositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema. Hepatology 24, 919-923 (1996)
106. Bothwell J. H., C. Rae, R. M. Dixon, P. Styles & K. K. Bhakoo: Hypo-osmotic swelling-activated release of organic osmolytes in brain slices: implications for brain oedema in vivo. J Neurochem 11, 1632-1640 (2001)
107. 13C] nuclear magnetic resonance study. Hepatology 37, 420-428 (2003)
108. I3C-NMR study. Gastroenterology 125(3), 815-24 (2003)
109. Vaquero J. & A. T. Blei: Cooling the patient with acute liver failure. Gastroenterology 127, 1626-1629 (2004)
110. Zielińska M., R. O. Law & J. Albrecht: Excitotoxic mechanism of cell swelling in rat cerebral cortical slices treated acutely with ammonia. Neurochem Int 43, 299-303 (2003)
111. Albrecht J.: Glucose-derived osmolytes and energy impairment in brain edema accompanying liver failure: the role of glutamine reevaluated. Gastroenterology 125, 976-978 (2003)
112. Ziemińska E., M. Dolinska, J. W. Lazarewicz & J. Albrecht: Induction of permeability transition and swelling of rat brain mitochondria by glutamine. Neurotoxicology 21, 295-300 (2000)
113. Murthy C. R., K. V. Rama Rao, G. Bai & M. D. Norenberg: Ammonia-induced production of free radicals in primary cultures of rat astrocytes. J Neurosci Res 66, 282-288 (2001)
114. Rama Rao K. V., A. R. Jayakumar & M. D. Norenberg: Induction of the mitochondrial permeability transition in cultured astrocytes by glutamine. Neurochem Int 43, 517-523 (2003)
115. Jayakumar A. R., K. V. Rama Rao, A. Schousboe & M. D. Norenberg: Glutamine-induced free radical production in cultured astrocytes. Glia 46, 296-301 (2004)
116. Rigotti P., T. Jonung, J. C. Peters, J. H. James & J. E. Fischer: Methionine sulfoximine prevents accumulation of large neutral amino acids in brain of portacaval shunted rats. J Neurochem 44, 929-933 (1985)
117. Mans A. M., M. R. DeJoseph, D. W. Davis, J. R. Vina & R. A. Hawkins: Early establishment of cerebral dysfunction after portacaval shunting. Am J Physiol 259, E104-E110 (1990)
118. Moroni F., R. Carpenedo, I. Venturini, M. Baraldi & M. L. Zeneroli: Oxindole in pathogenesis of hepatic encephalopathy. Lancet 351, 1861 (1998)
119. Hilgier W., M. Puka & J. Albrecht: Characteristics of large neutral amino acid- induced release of preloaded glutamine from rat cerebral capillaries in vitro: Effects of ammonia, hepatic encephalopathy and γ- glutamyltranspeptidase inhibitors. J Neurosci Res 32, 221-226 (1992)
120. Cangiano C., P. Cardelli-Cangiano, J. H. James, F. Rossi-Fanelli, M. A. Patrizi, K. A. Brackett, R. Strom & J. E. Fischer: Brain microvessels take up large neutral amino acids in exchange for glutamine. J Biol Chem 258, 8949-8954 (1983)
121. Wischmeyer P. E.: Glutamine and heat shock protein expression. Nutrition 18, 225-228 (2002)
122. Curi R., C. J. Lagranha, S. Q. Doi, D. F. Sellitti, J. Procopio, T. C. Pithon-Curi, M. Corless & P. Newsholme: Molecular mechanisms of glutamine action. J Cell Physiol 204(2), 392-401 (2005)
123. Szeliga M., M. Sidoryk, E. Matyja, P. Kowalczyk & J. Albrecht: Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas. Neurosci Lett 374, 171-173 (2005)